Evidence map›Paper›PMID 21167347›Full record

Trial reportAmerican heart journal2011

Effects of smoking and smoking cessation on lipids and lipoproteins: outcomes from a randomized clinical trial.

Adam D Gepner, Megan E Piper, Heather M Johnson, Michael C Fiore, Timothy B Baker, James H Stein

Abstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in American heart journal, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 116 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
116citing papers in PubMed, 9 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

116 citing papers in PubMed, 9 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Antidepressants for smoking cessation.The Cochrane database of systematic reviews · 2020
    Pooled it
  5. 2018 Guidelines for the management of dyslipidemia.The Korean journal of internal medicine · 2019
    Guideline
  6. Pooled it
  7. Guideline
  8. Nicotine replacement therapy versus control for smoking cessation.The Cochrane database of systematic reviews · 2018
    Pooled it
  9. Antidepressants for smoking cessation.The Cochrane database of systematic reviews · 2014
    Pooled it
  10. Trial
  11. Trial
  12. Trial
  13. Smokers and Postcessation Weight Gain After Acute Coronary Syndrome.Journal of the American Heart Association · 2017
    Trial
  14. Trial
  15. Trial
  16. Smoking cessation and quality of life: changes in life satisfaction over 3 years following a quit attempt.Annals of behavioral medicine : a publication of the Society of Behavioral Medicine · 2012
    Trial
  17. Trial
  18. Trial
  19. Features of Lipid Disorders in Cardiovascular-Kidney-Metabolic Syndrome.International journal of molecular sciences · 2026
    Review
  20. Article

56 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Adam D GepnerUniversity of Wisconsin Schoolof Medicine and Public Health, Madison, WI 53792, USA.
Megan E Piper
Heather M Johnson
Michael C Fiore
Timothy B Baker
James H Stein

Funding

INSTITUTIONAL CTSA (UW-MADISON): CLINICAL TRIALSUL1RR025011 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI DREZNER, MARC KENNETH · 2007 to 2011
$29.5M
Training Program in Translational Cardiovascular Science (TPTCS)T32HL007936 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI Lee Lochbaum Eckhardt, Gail A Robertson · 2001 to 2026
$11.6M
Institutional Clinical and Translational Science Award (UW-Madison)KL2RR025012 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI DREZNER, MARC KENNETH · 2007 to 2011
$11.1M
Tobacco Dependence: Treatment and OutcomesP50DA019706 · NIDA · UNIVERSITY OF WISCONSIN-MADISON · PI BAKER, TIMOTHY B · 2004 to 2008
$8.6M
Training in Translational Tobacco ScienceK05CA139871 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI BAKER, TIMOTHY B · 2008 to 2012
$850k
NCI NIH HHS K05 CA139871NCRR NIH HHS KL2 RR025012NCRR NIH HHS UL1 RR025011NHLBI NIH HHS T32 HL007936NIDA NIH HHS P50 DA019706Wellcome Trust
6 · The paper itself

Abstract

backgroundthe effects of smoking and smoking cessation on lipoproteins have not been studied in a large contemporary group of smokers. This study was designed to determine the effects of smoking cessation on lipoproteins.

methodsthis was a 1-year, prospective, double-blind, randomized, placebo-controlled clinical trial of the effects of 5 smoking cessation pharmacotherapies. Fasting nuclear magnetic resonance spectroscopy lipoprotein profiles were obtained before and 1 year after the target smoking cessation date. The effects of smoking cessation and predictors of changes in lipoproteins after 1 year were identified by multivariable regression.

resultsthe 1,504 current smokers were (mean [SD]) 45.4 (11.3) years old and smoked 21.4 (8.9) cigarettes per day at baseline. Of the 923 adult smokers who returned at 1 year, 334 (36.2%) had quit smoking. Despite gaining more weight (4.6 kg [5.7] vs 0.7 kg [5.1], P < .001], abstainers had increases in high-density lipoprotein cholesterol (HDL-C) (2.4 [8.3] vs 0.1 [8.8] mg/dL, P < .001), total HDL (1.0 [4.6] vs -0.3 micromol/L [5.0], P < .001), and large HDL (0.6 [2.2] vs 0.1 [2.1] micromol/L, P = .003) particles compared with continuing smokers. Significant changes in low-density lipoprotein (LDL) cholesterol and particles were not observed. After adjustment, abstinence from smoking (P < .001) was independently associated with increases in HDL-C and total HDL particles. These effects were stronger in women.

conclusionsdespite weight gain, smoking cessation improved HDL-C, total HDL, and large HDL particles, especially in women. Smoking cessation did not affect LDL or LDL size. Increases in HDL may mediate part of the reduced cardiovascular disease risk observed after smoking cessation.

Indexed as

Smoking CessationCardiovascular DiseasesCholesterol, HDLCholesterol, LDLDouble-Blind MethodFemaleFollow-Up StudiesHumansLipoproteinsMagnetic Resonance SpectroscopyMaleMiddle AgedPrognosisProspective StudiesSmokingSmoking PreventionCholesterol, HDLCholesterol, LDLLipoproteins

Identifiers

PMID21167347
PMCPMC3110741

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.